Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Morphic Holding, Inc. - Common Stock (NQ:MORF)

56.99 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Morphic Holding, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Morphic to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Morphic Therapeutic
Via GlobeNewswire
News headline image
Morphic Announces Initiation of EMERALD-2 Phase 2b Clinical Trial of MORF-057 in Patients with Moderate-to-Severe Ulcerative Colitis
First patient dosed in global study of oral α4β7 integrin inhibitor 
From Morphic Therapeutic
Via GlobeNewswire
News headline image
Morphic Announces Participation in 2022 Jefferies London Healthcare Conference
From Morphic Therapeutic
Via GlobeNewswire
News headline image
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2022
From Morphic Therapeutic
Via GlobeNewswire
News headline image
Morphic Presents New Positive MORF-057 Phase 1 Data at American College of Gastroenterology Annual Meeting 2022
From Morphic Therapeutic
Via GlobeNewswire
News headline image
Morphic Announces Complete Enrollment of EMERALD-1 Main Cohort Ahead of Projections
Phase 2a trial of MORF-057 in patients with ulcerative colitis will extend enrollment to allow patients currently screened to enter study if eligible 
From Morphic Therapeutic
Via GlobeNewswire
News headline image
Morphic Presents New Positive MORF-057 Phase 1 Data at UEG Week 2022
From Morphic Therapeutic
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.